Literature DB >> 7945388

The cloning and expression of a human creatine transporter.

I Sora1, J Richman, G Santoro, H Wei, Y Wang, T Vanderah, R Horvath, M Nguyen, S Waite, W R Roeske.   

Abstract

A human creatine transporter (hCRT-BS2M) cDNA clone was isolated from a human brainstem/spinal cord using a PCR and phage plaque hybridization based technique. This clone included an open reading frame of 1,905 base pairs(bp) within a 2,283bp cDNA. Northern blot hybridization detected the expression of corresponding mRNAs most prominently in the skeletal muscle, heart and kidney. Peptide sequence analysis of the hCRT-BS2M protein product revealed 12 putative transmembrane domains. The predicted protein sequence further demonstrates that the hCRT-BS2M has highly conserved amino acid identity with the other members of the sodium dependent plasma membrane transporter family. Transient expression of the hCRT-BS2M in COS-7 cells demonstrates sodium dependent [14C]creatine uptake with a KM value of 14.9 +/- 3.0 microM (n = 5) that is attenuated by creatine and selective structural analogues of creatine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945388     DOI: 10.1006/bbrc.1994.2475

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

Review 1.  Role of plasma membrane transporters in muscle metabolism.

Authors:  A Zorzano; C Fandos; M Palacín
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

2.  Downregulation of the creatine transporter SLC6A8 by JAK2.

Authors:  Manzar Shojaiefard; Zohreh Hosseinzadeh; Shefalee K Bhavsar; Florian Lang
Journal:  J Membr Biol       Date:  2012-03-11       Impact factor: 1.843

3.  Functional and electrophysiological characterization of four non-truncating mutations responsible for creatine transporter (SLC6A8) deficiency syndrome.

Authors:  Vassili Valayannopoulos; Naziha Bakouh; Michel Mazzuca; Luc Nonnenmacher; Laurence Hubert; Fatna-Léa Makaci; Allel Chabli; Gajja S Salomons; Caroline Mellot-Draznieks; Emilie Brulé; Pascale de Lonlay; Hervé Toulhoat; Arnold Munnich; Gabrielle Planelles; Yves de Keyzer
Journal:  J Inherit Metab Dis       Date:  2012-05-30       Impact factor: 4.982

4.  X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome.

Authors:  G S Salomons; S J van Dooren; N M Verhoeven; K M Cecil; W S Ball; T J Degrauw; C Jakobs
Journal:  Am J Hum Genet       Date:  2001-04-20       Impact factor: 11.025

Review 5.  Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.

Authors:  Peter J Adhihetty; M Flint Beal
Journal:  Neuromolecular Med       Date:  2008-11-13       Impact factor: 3.843

6.  Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans.

Authors:  C B Item; S Stöckler-Ipsiroglu; C Stromberger; A Mühl; M G Alessandrì; M C Bianchi; M Tosetti; F Fornai; G Cioni
Journal:  Am J Hum Genet       Date:  2001-09-10       Impact factor: 11.025

7.  Creatine transporters: a reappraisal.

Authors:  Oliver Speer; Lukas J Neukomm; Robyn M Murphy; Elsa Zanolla; Uwe Schlattner; Hugues Henry; Rodney J Snow; Theo Wallimann
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

8.  Fenugreek increases insulin-stimulated creatine content in L6C11 muscle myotubes.

Authors:  Kristyen A Tomcik; William J Smiles; Donny M Camera; Helmut M Hügel; John A Hawley; Rani Watts
Journal:  Eur J Nutr       Date:  2016-01-05       Impact factor: 5.614

9.  Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells.

Authors:  Rolando B Ceddia; Gary Sweeney
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

Review 10.  X-linked creatine transporter defect: an overview.

Authors:  G S Salomons; S J M van Dooren; N M Verhoeven; D Marsden; C Schwartz; K M Cecil; T J DeGrauw; C Jakobs
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.